HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

GABAA receptor and anti-titin antibody encephalitis in a patient with thymoma.

Abstract
Autoimmune encephalitis (AE) associated to antibodies against GABA A R is a rare form of encephalitis. On the other hand, thymoma has been linked to antibodies against both muscular and neuronal epitopes, even if concurrent positivity for more than one antibody is exceptional, and their contribution to the clinical course and treatment decision is unclear. We report a case of a 73-year-old male with AE associated with thymoma secreting both anti-GABAaR and anti-titin antibodies. Clinical presentation included status epilepticus, behavioural changes and cognitive decline. While the status was stopped with lacosamide, AE treatment included first- and second-line immunomodulation, in addition to thymoma's removal. Nonetheless, the patient experienced a worsening in cognitive and behavioural status.
AuthorsMaria Tappatà, Maria Pia Giannoccaro, Michele Romoli, Stefania Testoni, Giorgia Arnone, Laura Piccolo, Piergiorgio Solli, Anna Zaniboni, Federica Naldi, Keivan Kaveh Moghadam, Nazarena Nannini, Stefania Damiani, Rocco Liguori, Andrea Zini
JournalNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (Neurol Sci) Vol. 43 Issue 9 Pg. 5633-5636 (Sep 2022) ISSN: 1590-3478 [Electronic] Italy
PMID35708792 (Publication Type: Case Reports, Journal Article)
Copyright© 2022. Fondazione Società Italiana di Neurologia.
Chemical References
  • Autoantibodies
  • Receptors, GABA-A
Topics
  • Aged
  • Autoantibodies
  • Encephalitis
  • Hashimoto Disease
  • Humans
  • Male
  • Receptors, GABA-A
  • Thymoma (complications)
  • Thymus Neoplasms (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: